BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 29053791)

  • 1. Pharmacological targeting of apelin impairs glioblastoma growth.
    Harford-Wright E; Andre-Gregoire G; Jacobs KA; Treps L; Le Gonidec S; Leclair HM; Gonzalez-Diest S; Roux Q; Guillonneau F; Loussouarn D; Oliver L; Vallette FM; Foufelle F; Valet P; Davenport AP; Glen RC; Bidere N; Gavard J
    Brain; 2017 Nov; 140(11):2939-2954. PubMed ID: 29053791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The glycoprotein GP130 governs the surface presentation of the G protein-coupled receptor APLNR.
    Trillet K; Jacobs KA; André-Grégoire G; Thys A; Maghe C; Cruard J; Minvielle S; Diest SG; Montagnac G; Bidère N; Gavard J
    J Cell Biol; 2021 Sep; 220(9):. PubMed ID: 34287648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo genetic profiling and cellular localization of apelin reveals a hypoxia-sensitive, endothelial-centered pathway activated in ischemic heart failure.
    Sheikh AY; Chun HJ; Glassford AJ; Kundu RK; Kutschka I; Ardigo D; Hendry SL; Wagner RA; Chen MM; Ali ZA; Yue P; Huynh DT; Connolly AJ; Pelletier MP; Tsao PS; Robbins RC; Quertermous T
    Am J Physiol Heart Circ Physiol; 2008 Jan; 294(1):H88-98. PubMed ID: 17906101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apelin/APJ signaling is a critical regulator of statin effects in vascular endothelial cells--brief report.
    McLean DL; Kim J; Kang Y; Shi H; Atkins GB; Jain MK; Chun HJ
    Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2640-3. PubMed ID: 22995518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apelin Controls Angiogenesis-Dependent Glioblastoma Growth.
    Frisch A; Kälin S; Monk R; Radke J; Heppner FL; Kälin RE
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32545380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of apelin expression switches endothelial cells from proliferative to mature state in pathological retinal angiogenesis.
    Kasai A; Ishimaru Y; Higashino K; Kobayashi K; Yamamuro A; Yoshioka Y; Maeda S
    Angiogenesis; 2013 Jul; 16(3):723-34. PubMed ID: 23640575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Apelin signalisation and vascular physiopathology].
    Masri B; van den Berghe L; Sorli C; Knibiehler B; Audigier Y
    J Soc Biol; 2009; 203(2):171-9. PubMed ID: 19527631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial cells create a stem cell niche in glioblastoma by providing NOTCH ligands that nurture self-renewal of cancer stem-like cells.
    Zhu TS; Costello MA; Talsma CE; Flack CG; Crowley JG; Hamm LL; He X; Hervey-Jumper SL; Heth JA; Muraszko KM; DiMeco F; Vescovi AL; Fan X
    Cancer Res; 2011 Sep; 71(18):6061-72. PubMed ID: 21788346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apelin/APJ signaling system: a potential link between adipose tissue and endothelial angiogenic processes.
    Kunduzova O; Alet N; Delesque-Touchard N; Millet L; Castan-Laurell I; Muller C; Dray C; Schaeffer P; Herault JP; Savi P; Bono F; Valet P
    FASEB J; 2008 Dec; 22(12):4146-53. PubMed ID: 18708591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apelin ameliorates TNF-α-induced reduction of glycogen synthesis in the hepatocytes through G protein-coupled receptor APJ.
    Chu J; Zhang H; Huang X; Lin Y; Shen T; Chen B; Man Y; Wang S; Li J
    PLoS One; 2013; 8(2):e57231. PubMed ID: 23437347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rbpj Deficiency Disrupts Vascular Remodeling via Abnormal Apelin and Cdc42 (Cell Division Cycle 42) Activity in Brain Arteriovenous Malformation.
    Adhicary S; Fanelli K; Nakisli S; Ward B; Pearce I; Nielsen CM
    Stroke; 2023 Jun; 54(6):1593-1605. PubMed ID: 37051908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apelin-APJ signaling is a critical regulator of endothelial MEF2 activation in cardiovascular development.
    Kang Y; Kim J; Anderson JP; Wu J; Gleim SR; Kundu RK; McLean DL; Kim JD; Park H; Jin SW; Hwa J; Quertermous T; Chun HJ
    Circ Res; 2013 Jun; 113(1):22-31. PubMed ID: 23603510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells.
    Vengoji R; Macha MA; Nimmakayala RK; Rachagani S; Siddiqui JA; Mallya K; Gorantla S; Jain M; Ponnusamy MP; Batra SK; Shonka N
    J Exp Clin Cancer Res; 2019 Jun; 38(1):266. PubMed ID: 31215502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laser-induced choroidal neovascularization in mice attenuated by deficiency in the apelin-APJ system.
    Hara C; Kasai A; Gomi F; Satooka T; Sakimoto S; Nakai K; Yoshioka Y; Yamamuro A; Maeda S; Nishida K
    Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):4321-9. PubMed ID: 23722395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apelin, the Devil Inside Brain Tumors.
    Harford-Wright E; Gavard J
    J Exp Neurosci; 2018; 12():1179069518759680. PubMed ID: 29535551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Essential role of Apelin signaling during lymphatic development in zebrafish.
    Kim JD; Kang Y; Kim J; Papangeli I; Kang H; Wu J; Park H; Nadelmann E; Rockson SG; Chun HJ; Jin SW
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):338-45. PubMed ID: 24311379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunocytochemical localisation of the apelin receptor, APJ, to human cardiomyocytes, vascular smooth muscle and endothelial cells.
    Kleinz MJ; Skepper JN; Davenport AP
    Regul Pept; 2005 Mar; 126(3):233-40. PubMed ID: 15664671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of serine 348 on the apelin receptor as a novel regulatory phosphorylation site in apelin-13-induced G protein-independent biased signaling.
    Chen X; Bai B; Tian Y; Du H; Chen J
    J Biol Chem; 2014 Nov; 289(45):31173-87. PubMed ID: 25271156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spatial and temporal role of the apelin/APJ system in the caliber size regulation of blood vessels during angiogenesis.
    Kidoya H; Ueno M; Yamada Y; Mochizuki N; Nakata M; Yano T; Fujii R; Takakura N
    EMBO J; 2008 Feb; 27(3):522-34. PubMed ID: 18200044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination therapy targeting integrins reduces glioblastoma tumor growth through antiangiogenic and direct antitumor activity and leads to activation of the pro-proliferative prolactin pathway.
    Oliveira-Ferrer L; Wellbrock J; Bartsch U; Penas EM; Hauschild J; Klokow M; Bokemeyer C; Fiedler W; Schuch G
    Mol Cancer; 2013 Nov; 12(1):144. PubMed ID: 24257371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.